News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
98,911 Results
Type
Article (7233)
Company Profile (41)
Press Release (91633)
Multimedia
Podcasts (18)
Webinars (2)
Section
Business (28194)
Career Advice (129)
Deals (4074)
Drug Delivery (41)
Drug Development (14272)
Employer Resources (12)
FDA (3011)
Job Trends (2142)
News (50095)
Policy (6144)
Tag
2027 Pharm Country Standard (2)
Academia (435)
Accelerated approval (15)
Adcomms (7)
Allergies (49)
Alliances (9169)
ALS (36)
Alzheimer's disease (344)
Antibody-drug conjugate (ADC) (115)
Approvals (2984)
Artificial intelligence (127)
Autoimmune disease (56)
Automation (9)
Bankruptcy (19)
Best Places to Work (1802)
BIOSECURE Act (19)
Biosimilars (142)
Biotechnology (30)
Bladder cancer (42)
Brain cancer (14)
Breast cancer (129)
Cancer (1009)
Cardiovascular disease (51)
Career advice (117)
Career pathing (5)
CAR-T (52)
CDC (9)
Cell therapy (177)
Cervical cancer (8)
Clinical research (12445)
Collaboration (463)
Compensation (98)
Complete response letters (24)
COVID-19 (594)
CRISPR (12)
C-suite (168)
Cystic fibrosis (17)
Data (1411)
Denatured (6)
Depression (15)
Diabetes (72)
Diagnostics (619)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (93)
Drug pricing (43)
Drug shortages (1)
Duchenne muscular dystrophy (77)
Earnings (10268)
Editorial (17)
Employer branding (3)
Employer resources (10)
Events (12799)
Executive appointments (173)
FDA (3818)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (295)
Gene editing (45)
Generative AI (18)
Gene therapy (184)
GLP-1 (153)
Government (1407)
Grass and pollen (1)
Guidances (81)
Healthcare (1967)
HIV (11)
Huntington's disease (14)
IgA nephropathy (20)
Immunology and inflammation (96)
Immuno-oncology (26)
Indications (25)
Infectious disease (665)
Inflammatory bowel disease (67)
Inflation Reduction Act (7)
Influenza (36)
Intellectual property (40)
Interviews (11)
IPO (1873)
IRA (17)
Job creations (395)
Job search strategy (109)
JPM (9)
Kidney cancer (3)
Labor market (8)
Layoffs (68)
Leadership (3)
Legal (573)
Liver cancer (13)
Longevity (9)
Lung cancer (155)
Lymphoma (71)
Machine learning (14)
Management (2)
Manufacturing (313)
MASH (31)
Medical device (1207)
Medtech (1219)
Mergers & acquisitions (2398)
Metabolic disorders (186)
Multiple sclerosis (42)
NASH (3)
Neurodegenerative disease (72)
Neuropsychiatric disorders (8)
Neuroscience (574)
NextGen: Class of 2026 (707)
Non-profit (359)
Now hiring (15)
Obesity (71)
Opinion (68)
Ovarian cancer (40)
Pain (23)
Pancreatic cancer (32)
Parkinson's disease (44)
Partnered (10)
Patents (71)
Patient recruitment (87)
Peanut (26)
People (8411)
Pharmaceutical (9)
Pharmacy benefit managers (7)
Phase 1 (4107)
Phase 2 (5165)
Phase 3 (4542)
Pipeline (1336)
Policy (124)
Postmarket research (298)
Preclinical (1607)
Press Release (66)
Prostate cancer (39)
Psychedelics (6)
Radiopharmaceuticals (42)
Rare diseases (200)
Real estate (971)
Recruiting (4)
Regulatory (5484)
Reports (11)
Research institute (397)
Resumes & cover letters (11)
Rett syndrome (5)
RNA editing (3)
RSV (17)
Schizophrenia (28)
Series A (52)
Series B (31)
Service/supplier (3)
Sickle cell disease (20)
Special edition (5)
Spinal muscular atrophy (23)
Sponsored (14)
Startups (615)
State (1)
Stomach cancer (5)
Supply chain (17)
Tariffs (21)
The Weekly (12)
Vaccines (299)
Venture capital (15)
Weight loss (29)
Women's health (7)
Date
Today (24)
Last 7 days (114)
Last 30 days (457)
Last 365 days (6107)
2026 (724)
2025 (6059)
2024 (6559)
2023 (7013)
2022 (9138)
2021 (9554)
2020 (8235)
2019 (5900)
2018 (4586)
2017 (5125)
2016 (4673)
2015 (5356)
2014 (3763)
2013 (2946)
2012 (3015)
2011 (3176)
2010 (2615)
Location
Africa (100)
Alabama (18)
Alaska (1)
Arizona (19)
Arkansas (2)
Asia (8559)
Australia (919)
California (2230)
Canada (435)
China (407)
Colorado (48)
Connecticut (60)
Delaware (100)
Europe (14686)
Florida (304)
Georgia (38)
Hawaii (1)
Idaho (14)
Illinois (96)
India (35)
Indiana (57)
Iowa (10)
Japan (99)
Kansas (7)
Kentucky (13)
Louisiana (2)
Maine (5)
Maryland (445)
Massachusetts (1621)
Michigan (32)
Minnesota (75)
Mississippi (4)
Missouri (23)
Montana (5)
Nebraska (1)
Nevada (12)
New Hampshire (5)
New Jersey (739)
New Mexico (4)
New York (568)
North Carolina (299)
North Dakota (9)
Northern California (1075)
Ohio (65)
Oklahoma (11)
Oregon (5)
Pennsylvania (319)
Puerto Rico (3)
Rhode Island (6)
South America (141)
South Carolina (3)
Southern California (926)
Tennessee (7)
Texas (328)
United States (7562)
Utah (45)
Virginia (27)
Washington D.C. (8)
Washington State (172)
West Virginia (1)
Wisconsin (15)
98,911 Results for "wuxi biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager
February 3, 2026
·
2 min read
Press Releases
WuXi Biologics and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Development and Manufacturing of Innovative Bispecific Antibody
January 29, 2026
·
4 min read
Press Releases
WuXi Biologics Achieves ISO 20400 Certification, Setting Benchmark in Sustainable Procurement
January 5, 2026
·
3 min read
Press Releases
HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline
January 26, 2026
·
5 min read
Press Releases
JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth
January 15, 2026
·
9 min read
Press Releases
WuXi Biologics Recognized by Hong Kong ESG Reporting Awards 2025 for Outstanding ESG Disclosure
December 24, 2025
·
3 min read
Press Releases
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year
October 10, 2025
·
3 min read
Press Releases
WuXi Biologics Reports Solid 2025 Interim Results
August 20, 2025
·
16 min read
Manufacturing
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye İlaç ve Tıbbi Cihaz Kurumu (TITCK)
September 17, 2025
·
3 min read
1 of 9,892
Next
